Evaluation of Disordered Puberty

Brook's Clinical Pediatric Endocrinology: Sixth Edition

Volumn , Issue , 2010, Pages 213-238

  Dattani, Mehul T ^a   Tziaferi, Vaitsa ^a   Hindmarsh, Peter C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti M llerian hormone (AMH) and same transforming growth factor; Dehydroepiandrosterone and androstenedione increasing concentration; Evaluation of disordered puberty; Genetic factors in onset of puberty; Hypogonadotropic hypogonadism absence of spontaneous pubertal development; McCune Albright syndrome (MAS) multisystem disorder, classic triad of irregularly edged hyperpigmented macules

Indexed keywords

EID: 84886055323     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444316728.ch10     Document Type: Chapter

References (149)

1. Grumbach MM, Styne DM. Puberty, ontogeny, neuroendocrinology, physiology, and disorders. In: Wilson JD, Foster DW, Kronenberg MD, Larsen PR, eds. Williams Textbook of Endocrinology, 9th edn. Philadelphia: WB Saunders; 1998: 1509-1625.
2. Tanner JM. The trend toward earlier menarche in London, Oslo, Copenhagen, the Netherlands and Hungary. Nature 1973; 243: 95.
3. Parent A-S, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon J-P. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends and changes after migration. Endocrine Rev 2003; 24: 668-693.
4. Evelith PB. Population differences in growth: environmental and genetic factors. In: Falkner F, Tanner JM, eds. Human Growth. New York: Plenum Press, 1979: 373-394.
5. Proos LA, Hofvander Y, Tuvemo T. Menarcheal age and growth pattern of Indian girls adopted in Sweden. I. Menarcheal age. Acta Paediatr Scand 1991; 80: 852-858.
6. Hartz AJ, Barboriak PN, Wong A. The association of obesity with infertility and related menstrual abnormalities in women. Int J Obes 1979; 3: 5773.
7. Osler DC, Crawford JD. Examination of the hypothesis of a critical weight at menarche in ambulatory and bedridden mentally retarded girls. Pediatrics 1973; 51: 674-679.
8. Takaishi, M. Secular changes in growth of Japanese children. J Pediatr Endocrinol 1994; 7: 163-173.
9. Must A, Naumova EN, Phillips SM, Blum M, Dawson-Hughes B, Rand WM. Childhood overweight and maturational timing in the development of adult overweight and fatness: the Newton Girls Study and its follow-up. Pediatrics 2005; 116: 620-627.
10. Zukauskaite S, Lasiene D, Lasas L, Urbonaite B, Hindmarsh P. Onset of breast and pubic hair development in 1231 preadolescent Lithuanian schoolgirls. Arch Dis Child 2005; 90: 932-936.
11. Sloboda DM, Hart R, Doherty DA, Pennell CE, Hickey M. Age at menarche: influences of prenatal and postnatal growth. J Clin Endocrinol Metab 2007; 92: 46-50.
12. Mul D, Fredriks M, van Buuren S, Oosdijk W, Verloove-Vanhorick SP, Wit JM. Pubertal development in the Netherlands 1965-1997. Pediatric Res 2001; 50: 479-486.
13. de la Puente ML, Canela J, Alvarez J, Salleras L, Vicens-Calvet E. Cross-sectional growth study of the child and adolescent population of Catalonia (Spain). Ann Hum Biol 1997; 24: 435-452.
14. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
15. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23.
16. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 1999; 158: 417-433.
17. Ross GT. Follicular development: the life cycle of the follicle and puberty. In: Grumbach MM, Sizonenko PC, Aubert MI, eds. Control of the Onset of Puberty. Baltimore: Williams & Wilkins, 1990: 376-386.
18. Stanhope R, Adams J, Jacobs HS, et al. Ovarian ultrasound assessment in normal children, idiopathic precocious puberty, and during low dose pulsatile gonadotrophin releasing hormone treatment of hypogonadotrophic hypogonadism. Arch Dis Child 1985; 60: 116-119.
19. Salardi S, Orsini LF, Cacciari E, Partesotti S, Brondelli L, Cicognani A, et al. Pelvic ultrasonography in girls with precocious puberty, congenital adrenal hyperplasia, obesity, or hirsutism. J Pediatr 1988; 112: 880-887.
20. Bridges NA, Cooke A, Healy MJ, Hindmarsh PC, Brook CG. Standards for ovarian volume in childhood and puberty. Fertil Steril 1993; 60: 456-460.
21. Haber HP, Ranke MB. Pelvic ultrasonography in Turner syndrome: standards for uterine and ovarian volume. J Ultrasound Med 1999; 18: 271-276.
22. Gondos B, Kogan SJ. Testicular development during puberty. In: Grumbach MM, Sizonenko PC, Aubert ML, et al., eds. Control of the Onset of Puberty. Baltimore: Williams & Wilkins 1990: 387-402.
23. Nielsen CT, Skakkebaek NE, Richardson DW, Darling JA, Hunter WM, Jorgensen M, et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab 1986; 62: 532-535.
24. Janczewski Z, Bablok L. Semen characteristics in pubertal boys. II. Semen quality in relation to bone age. Arch Androl 1985; 15: 207-211.
25. Braunstein GD. Gynecomastia. N Engl J Med 2007; 357: 1229-1237.
26. Bachrach LK, Hastie T, Wang M, et al. Bone mineral acquisition in healthy Asian, Hispanic, black and Caucaisan youth: a longitudinal study. J Clin Endocrinol Metab 1999; 84: 4702-4712.
27. Ferrari S, Rizzoli R, Slosman D, Bonjour JP. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998; 83: 358-361.
28. Barr SI, McKay HA. Nutrition, exercise, and bone status in youth. Int J Sport Nutr 1998; 8: 124-142.
29. Kardinaal AF, Ando S, Charles P, Charzewska J, Rotily M, Veaeaneanen K, et al. Dietary calcium and bone density in adolescent girls and young women in Europe. J Bone Min Res 1999; 14: 583-592.
30. Rico H, Revilla M, Villa LF, Hernandez ER, Alvarez de Buergo M, Villa M. Body composition in children and Tanner's stages: a study with dual-energy X-ray absorptiometry. Metabolism 1993; 42: 967-970.
31. Cheek DB. Body composition, hormones, nutrition and adolescent growth. In: Grumbach MM, Grave GD, Mayer FE, eds. Control of the Onset of Puberty. New York: John Wiley & Sons, 1974: 424-447.
32. Tanner JM, Whitehouse RH, Marubini E, Resele LF. The adolescent growth spurt of boys and girls of the Harpenden growth study. Ann Hum Biol 1976; 3: 109-126.
33. Largo RH, Gasser TH, Prader A. Analysis of the adolescent growth spurt using smoothing spline functions. Ann Hum Biol 1978; 5: 421-434.
34. Martha PM Jr, Rogol AD, Veldhuis JD. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab 1989; 69: 563-570.
35. Veldhuis JD, Metzger DL, Martha PMJ, Mauras N, Kerrigan JR, Keenan B, et al. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamosomatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sexsteroid hormone replacement. J Clin Endocrinol Metab 1997; 82: 3414-3420.
36. Metzger DL, Kerrigan JR. Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence. J Clin Endocrinol Metab 1994; 79: 513-518.
37. Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biologic markers of bone turnover. Endocr Rev 1996; 17: 333-368.
38. Ross JL, Cassorla FG, Skerda MC, et al. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med 1984; 309: 1104-1106.
39. Grumbach MM, Auchus RJ. Estrogen: consequences and implication of human mutations in synthesis and action. J Clin Endocrinol Metab 1999; 84: 4677-4643.
40. Cutler GB. The role of estrogen in bone growth and maturation during childhood and adolescence. J Steroid Biochem Mol Biol 1997; 61: 141-144.
41. Ojeda SR, Lomniczi A, Mastronardi C, et al. Minireview: the neuroendocrine regulation of puberty -is the time ripe for a systems biology approach? Endocrinology 2006; 147: 1166-1174.
42. Bridges NA, Matthews DR, Hindmarsh PC, Brook CGD. Changes in gonadotrophin secretion during childhood and puberty. J Endocrinol 1994; 141: 169-176.
43. Adelman JP, Mason AJ, Hayflick JS, et al. Isolation of the gene and hypothalamic cDNA for the common precursor of gonadotropinreleasing hormone and prolactin release-inhibiting factor in human and rat. Proc Natl Acad Sci U S A 1986; 83: 179-183.
44. Schwanzel-Fukada M, Jorgensen KL, Bergen HT, et al. Biology of normal luteinizing hormone-releasing hormone neurons during and after their migration from olfactory placode. Endocr Rev 1992; 13: 623-634.
45. Seminara SB, Hayes FJ, Crowley WFJ. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev 1999; 19: 521-539.
46. Seminara SB, Crowley WF Jr. The importance of genetic defects in humans in elucidating the complexities of the hypothalamicpituitary-gonadal axis. Endocrinology 2001; 142: 2173-2177.
47. Seminara SB. The first kiss: a crucial role for kisspeptin-1 and its receptor, G-protein-coupled receptor 54, in puberty and reproduction. Natl Clin Pract Endocrinol Metab 2006; 2: 328-334
48. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000; 21: 551-583.
49. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003; 100: 10972-10976.
50. Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349: 1614-1627.
51. Semple RK, Achermann JC, Ellery J, et al. Two novel missense mutations in G protein-coupled receptor 54 in a pateint with hypogondotropic hypogonadism. J Clin Endocrinol Metab 2005; 90: 1849-1855.
52. Gurgel Teles M, Bianco SDC, Nahime Brito V, et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 2008; 358: 709-715.
53. Plant TM, Ramaswamy S, Dipietro MJ. Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges. Endocrinology 2006; 147: 1007-1013.
54. Wetsel WC, Valenca MM, Merchenthaler I, Liposits Z, Lopez FJ, Weiner RI, et al. Intrinsic pulsatile secretory activity of immortalized luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci U S A 1992; 89: 4149-4153.
55. Mitsushima D, Hei DL, Terasawa E. Gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty. Proc Natl Acad Sci U S A 1994; 91: 395-399.
56. Hazum E, Conn PM. Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor. Endocr Rev 1988; 9: 379-386.
57. Huckle W, Conn PM. Molecular mechanisms of gonadotropin releasing hormone action. II. The effector system. Endocr Rev 1988; 9: 387-395.
58. Huhtaniemi I, Jiang M, Nilsson C, Pettersson K. Mutations and polymorphisms in gonadotropin genes. Mol Cell Endocrinol 1999; 151: 89-94.
59. Layman LC. Mutations in human gonadotropin genes and their physiologic significance in puberty and reproduction. Fertil Steril 1999; 71: 201-218.
60. Lofrano-Porto A, Barcelos Barra G, Abdala Giacomini L, et al. Luteinising hormone beat mutation and hypogonadism in men and women. N Engl J Med 2007; 357: 897-904.
61. Reiter EO, Kulin HE, Hamwood SM. The absence of positive feedback between estrogen and luteinizing hormone in sexually immature girls. Pediatr Res 1974; 8: 740-745.
62. Filicori M, Butler JP, Crowley WFJ. Neuroendocrine regulation of the corpus luteum in the human. J Clin Invest 1999; 73: 1638-1647.
63. Russell DW, Wilson JD. Steroid 5 a hydroxylase: two genes/two enzymes. Annu Rev Med 1994; 63: 25-61.
64. Mahendroo MS, Mendelson CR, Simpson ER. Tissue specific and hormonally controlled alternative promoters regulate aromatase cyotchrome P450 gene expression in human adipose tissue. J Biol Chem 1993; 268: 19463-19470.
65. Lubahn DR, Joseph DR, Sar M, et al. The human androgen receptor: complementary dexoribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988; 2: 1265-1275.
66. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 1994; 94: 2475-2480.
67. Vale W, Bilezikjian LM, Rivier C. Reproductive and other roles of inhibins and activins. In: Knobil E, Neil JD, eds. Physiology of Reproduction, 2nd edn. New York: Raven Press, 1994: 1861-1878.
68. Andersson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, Simell O, et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998; 83: 675-681.
69. Hudson PL, Dougas I, Donahoe PK, et al. An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990; 70: 16-22.
70. Gluckman PD, Grumbach MM, Kaplan SL. The neuroendocrine regulation and function of growth hormone and prolactin in the mammalian fetus. Endocr Rev 1981; 2: 363-395.
71. Forest MG. Pituitary gonadotropin and sex steroid secretion during the first two years of life. In: Grumbach MM, Sizonenko PC, Aubert AU, eds. Control of the Onset of Puberty. Baltimore: Williams & Wilkins, 1990: 451-478.
72. Conte FA, Grumbach MM, Kaplan SL, Reiter EO. Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty. J Clin Endocrinol Metab 1980; 50: 163-168.
73. Nathwani NC, Hindmarsh PC, Massarano AA, Brook CGD. Gonadotrophin pulsatility in girls with the Turner syndrome: modulation by exogenous sex steroids. Clin Endocrinol 1998; 49: 107-113.
74. Dunkel L, Alfthan H, Stenman U, et al. Gonadal control of pulsatile secretion of luteinizing hormone and follicle-stimulating hormone in prepubertal boys evaluated by ultrasensitive time-resolved immunofluorometric assays. J Clin Endocrinol Metab 1990; 70: 107-114.
75. Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A. Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty. J Clin Endocrinol Metab 1999; 84: 29-37.
76. Farooqi IS, Jebb SA, Langmack G, et al. Brief report: effects of recombinant leptin therapy in a child with congeintal leptin defi-ciency. N Engl J Med 1999; 341: 879-884.
77. Ahmed ML, Ong KK, Morrell DJ, Cox L, Drayer N, Perry L, et al. Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab 1999; 84: 899-905.
78. Arslanian S, Suprasongsin C, Kalhan SC, Drash AL, Brna R, Janosky JE. Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity, and energy expenditure. Metab Clin Exp 1998; 47: 309-312.
79. Grumbach MM, Richards GE, Conte FA, et al. Clinical disorders of adrenal function and puberty: an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone. In: James VHT, Serio M, Giusti G, et al., eds. The Endocrine Function of the Human Adrenal Cortex, Serono Symposium. New York: Academic Press, 1977: 583-612.
80. Schiebinger RJ, Albertson BD, Cassorla FG, Bowyer DW, Geelhoed GW, Cutler GB Jr, et al. The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. J Clin Invest 1981; 67: 1177-1182.
81. Bridges NA, Christopher JA, Hindmarsh PC, Brook CGD. Sexual precocity: sex incidence and aetiology. Arch Dis Child 1994; 70: 116-118.
82. Lebrethon MC, Bourguignon JP. Management of central isosexual precocity: diagnosis, treatment and outcome. Curr Opin Pediatr 2000; 12: 394-399.
83. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign? Pediatrics 2003; 111: 47-51.
84. Pescovitz OH, Comite F, Hench K, et al. The NIH experience with precocious puberty: diagnostic subgroups and response to shortterm luteinizing hormone-releasing hormone analogue therapy. J Pediatr 1986; 108: 47-54.
85. Stanhope R, Brook CGD, Pringle PJ, Adams J, Jacobs HS. Induction of puberty by pulsatile gonadotrophin-releasing hormone. Lancet 1987; ii, 552-555.
86. Donaldson MDC, Stanhope R, Lee TJ, Price DA, Brook CGD, Savage DCL Gonadotrophin responses to GnRH in precocious puberty treated with GnRH analogue. Clin Endocrinol 1984; 21: 499-503.
87. Junier MP, WolffA, Hoffman G, Ma YJ, Ojeda SR. Effect of hypothalamic lesions that induce precocious puberty on the morphological and functional maturation of the luteinizing hormone releasing hormone neuronal system. Endocrinology 1992; 131: 787-798.
88. Mahachoklerwattana P, Kaplan SL, Grumbach MM The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 1993; 77: 118-124.
89. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukaemia. N Engl J Med 1989; 321: 143-151.
90. Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994; 78: 1282-1286.
91. Herman ME, Giddens AD, Sandler NE, Freidman NE. Sexual precocity in girls: an association with sexual abuse? Am J Dis Child 1988; 142: 431-433.
92. Dacou-Voutetakis C, Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH agonist analogue. Ann N Y Acad Sci U S A 1993; 687: 250-254.
93. Boepple PA, Frisch LS, Wierman HE, Hoffman WH, Crowley WF. The natural history of autonomous gonadal function, adrenarche and central puberty in gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 1992; 75: 1550-1555.
94. Rosenthal SM, Grumbach MM, Kaplan SL. Gonadotrophinindependent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab 1983; 57: 571-579.
95. Latronico AC, Abell AN, Arnhold IJP, Liu X, Lins TSS, Brito VN, et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotrophin-independent precocious puberty. J Clin Endocrinol Metab 1998; 83: 2435-2440.
96. Kremer H, Martens JWM, Van Reen M, Verhoef-Post M, Wit JM, Otten BJ, et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab 1999; 84: 1136-1140.
97. Iiri T, Herzmark P, Nakamoto JM, van Dop C, Bourne HR. Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function. Nature 1994; 371: 164-168.
98. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome: longterm follow up. JAMA 1986; 256: 2980-2984.
99. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Freidman E, Speigel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325: 1688-1695.
100. Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB Jr. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotrophin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 1988; 67: 474-479.
101. Stanhope R, Brook CGD. Thelarche variant: a new syndrome of precocious sexual maturation? Acta Endocrinol (Copenh) 1990; 123: 481-486.
102. Beck W, Stubbe P. Pulsatile secretion of luteinizing hormone and sleep-related gonadotrophin rhythms in girls with premature thelarche. Pediatrics 1984; 141: 168-170.
103. Anasti JN, Flack MR, Froehlich J, Nelson LM, Nisula BC. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80: 276-279.
104. Pringle PJ, Stanhope R, Hindmarsh PC, Brook CGD. Abnormal pubertal development in primary hypothyroidism. Clin Endocrinol 1988; 28: 479-486.
105. Adams DM, Young PC, Copeland KC. Pubic hair in infancy. Am J Dis Child 1992; 146: 149-151.
106. Ibanez L, Potau N, Francois I, de Zegher F. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998; 83: 3558-3562.
107. Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V. Isolated precocious pubarche: an approach. J Clin Endocrinol Metab 1994; 79: 582-589.
108. Ibanez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1599-1603.
109. Ehrhardt AA, Meyer-Bahlburg HFL. Psychosocial aspects of precocious puberty. Horm Res 1994; 4 (Suppl 2): 30-35.
110. Grunt JA, Midyett K, Simon SD, Lowe L. When should cranial magnetic resonance imaging be used in girls with early sexual development? J Pediatr Endocrinol Metab 2004; 17: 775-780.
111. Chalumeau M, Chemaitilly W, Trivin C, Adan L, Breart G, Brauner R. Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics 2002; 109: 61-67.
112. Chemaitilly W, Trivin C, Adan L, Gall V, Sainte-Rose C, Brauner R. Central precocious puberty: clinical and laboratory features. Clin Endocrinol 2002; 54: 289-294.
113. Donaldson M. Commentary. Arch Dis Child 2003; 88: 417-418.
114. Ng SM, Kumar Y, Cody D, Smth C, Didi M. Cranial MRI scans are indicated in all girls with central precocious puberty. Arch Dis Child 2003; 88: 414-417.
115. Brauner R. Central precocious puberty in girls: prediction of the aetiology. J Pediatr Endocrinol Metab 2005; 18: 845-847.
116. Honour JW, Price DA, Taylor NF, Marsden HB, Grant DB. Steroid biochemistry of virilising adrenal tumours in childhood. Eur J Pediatr 1984; 142: 165-169.
117. Lanes R, Gunczler P, Osuna JA. Effectiveness and limitations of the use of the gonadotropin-releasing hormone agonist leuprolide acetate in the diagnosis od delayed puberty in males. Horm Res 1997; 48: 1-4.
118. Ghai K, Cara KF, Rosenfield RL. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys: a clinical research center study. J Clin Endocrinol Metab 1995; 80: 2980-2986.
119. Wehkalampi K, Widen E, Laine T, Palotie A, Dunkel L. Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to a specialist clinic. J Clin Endocrinol Metab 2008; 93: 723-728.
120. Raivio T, Falardeau J, Dwyer A, et al. Reversal of hypogonadotropic hypogonadism. N Engl J Med 2007; 357: 863-873.
121. Dattani MT, Robinson ICAF. The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 2000; 57: 337-346.
122. Rugliari EI, Ballabio A. Kallman syndrome: from genetics to neurobiology. JAMA 1993; 270: 2713-2716.
123. Reutens AT, Achermann JC, Ito M, Gu WX, Habiby RL, Donohoue PA, et al. Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J Clin Endocrinol Metab 1999; 84: 504-511.
124. Hernandez Martin A, Gonzalez Sarmiento R, De-Unamuno P. Xlinked ichthyosis: an update. Br J Dermatol 1999; 141: 617-627.
125. Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 2007; 117: 457-463.
126. Legouis R, Hardelin JP, Levilliers J, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991; 67: 423-435.
127. Dodé C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33: 463-465.
128. Albuisson J, Pêcheux C, Carel JC, et al. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat 2005; 25: 98-99.
129. Trarbach EB, Silveira LG, Latronico AC. Genetic insights into human isolated gonadotropin deficiency. Pituitary 2007; 10: 381-391.
130. Salenave S, Chanson P, Bry H, et al. Kallman's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J Clin Endocrinol Metab 2008; 93: 758-763.
131. Dodé C, Teixeira L, Levilliers J, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006; 2: e175. Epub 2.
132. Pitteloud N, Zhang C, Pignatelli D, et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A 2007; 104: 17447-17452.
133. Prosser HM, Bradley A, Caldwell MA. Olfactory bulb hypoplasia in Prokr2 null mice stems from defective neuronal progenitor migration and differentiation. Eur J Neurosci 2007; 26: 3339-3344.
134. Lin L, Conway GS, Hill NR, Dattani MT, Hindmarsh PC, Achermann JC. A homozygous R262Q mutation in the gonadotropinreleasing hormone receptor presenting as constitutional delay of growth and puberty with subsequent borderline oligospermia. J Clin Endocrinol Metab 2006; 91: 5117-5121.
135. Beranova M, Oliveira LM, Bédécarrats GY, et al. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropinreleasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2001; 86: 1580-1588.
136. Achermann JC, Weiss J, Lee EJ, Jameson JL. Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol 2001; 179: 89-96.
137. Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001; 276: 34631-34636.
138. Kramer PR, Wray S. Novel gene expressed in nasal region influences outgrowth of olfactory axons and migration of luteinizing hormonereleasing hormone (LHRH) neurons. Genes Dev 2000; 14: 1824-1834.
139. Miura K, Acierno JS Jr, Seminara SB. Characterization of the human nasal embryonic LHRH factor gene, NELF, and a mutation screening among 65 patients with idiopathic hypogonadotropic hypogonadism (IHH). J Hum Genet 2004; 49: 265-268.
140. Chung RT, Misdraji J, Sahani DV. Case 33-200. A 43-year-old man with diabetes, hypogonadism, cirrhosis, arthralgias and fatigue. N Engl J Med 2006; 355: 1812-1819.
141. Oerter KE, Kamp GA, Munson PJ, Nienhaus AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 1993; 76: 357-361.
142. Dunkel L, Perheentupa J, Virtanen M, Maenpaa J. Gonadotropinreleasing hormone test and human chorionic gonadotropin test in the diagnosis of gonadotropin deficiency in prepubertal boys. J Pediatr 1985; 107: 388-392.
143. Bouloux PM, Handelsman DJ, Jockenhovel F, Nieschlag E, Rabinovici J, Frasa WL, et al. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod 2001; 16: 1592-1597.
144. Smals AG, Hermus AR, Boers GH, Pieters GF, Benraad TJ, Kloppenborg PW. Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1994; 78: 602-608.
145. Bakker B, Massa GG, Oostdijk W, Van Weel-Sipman MH, Vossen JM, Wit JM. Pubertal development and growth after total-body irradiation and bone marrow transplantation for hematological malignancies. Eur J Pediatr 2000; 159: 31-37.
146. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107-134.
147. Fraser IS, Russell P, Greco S, Robertson DM. Resistant ovary syndrome and premature ovarian failure in young women with galactosaemia. Clin Reprod Fertil 1986; 4: 133-138.
148. Brook CGD, Gasser T, Werder EA, Prader A, Vanderschueren-Lodewykx MA. Height correlations between parents and mature offspring in normal subjects and in subjects with Turner's and Klinefelter's and other syndromes. Ann Hum Biol 1977; 4: 17-22.
149. Smyth CM, Bremner WJ. Klinefelter syndrome. Arch Intern Med 1998; 158: 1309-1314.